53
Participants
Start Date
June 30, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
BIIB037
Participants receive a single dose of BIIB037 by intravenous (IV) infusion in cohorts assigned to the following ascending doses: .03 mg/kg, 1 mg/kg, 3 mg/kg, 10 mg/kg, 20 mg/kg, 30 mg/kg, and 60 mg/kg.
Placebo
Participants receive a single dose of matching BIIB037 placebo by intravenous (IV) infusion.
Compass Research, LLC, Orlando
Brain Matters Research, Delray Beach
Insight Clinical Trials, LLC, Beachwood
Lead Sponsor
Biogen
INDUSTRY